• Medientyp: E-Artikel
  • Titel: DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition
  • Beteiligte: Lu, Yuting; Xu, Junyu; Li, Yufeng; Wang, Ruoran; Dai, Chengqiu; Zhang, Bingqian; Zhang, Xinwen; Xu, Lei; Tao, Yunhua; Han, Ming; Guo, Ren; Wu, Qingqian; Wu, Linshi; Meng, Zhuoxian; Tan, Minjia; Li, Jingya
  • Erschienen: American Association for the Advancement of Science (AAAS), 2024
  • Erschienen in: Science Translational Medicine
  • Sprache: Englisch
  • DOI: 10.1126/scitranslmed.ade8647
  • ISSN: 1946-6234; 1946-6242
  • Schlagwörter: General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p> Impeded autophagy can impair pancreatic β cell function by causing apoptosis, of which DAP-related apoptosis-inducing kinase-2 (DRAK2) is a critical regulator. Here, we identified a marked up-regulation of DRAK2 in pancreatic tissue across humans, macaques, and mice with type 2 diabetes (T2D). Further studies in mice showed that conditional knockout (cKO) of DRAK2 in pancreatic β cells protected β cell function against high-fat diet feeding along with sustained autophagy and mitochondrial function. Phosphoproteome analysis in isolated mouse primary islets revealed that DRAK2 directly phosphorylated unc-51–like autophagy activating kinase 1 (ULK1) at Ser <jats:sup>56</jats:sup> , which was subsequently found to induce ULK1 ubiquitylation and suppress autophagy. ULK1-S56A mutation or pharmacological inhibition of DRAK2 preserved mitochondrial function and insulin secretion against lipotoxicity in mouse primary islets, Min6 cells, or INS-1E cells. In conclusion, these findings together indicate an indispensable role of the DRAK2-ULK1 axis in pancreatic β cells upon metabolic challenge, which offers a potential target to protect β cell function in T2D. </jats:p>